Masimo has officially bought Sound United but investors still have many questions about the deal, and the company's supply chain issues.

Analyst sees attractive growth drivers in contact lens and intraocular lens markets.

The drug-delivery system developed by BioSapien is a 3D-printed biodegradable and biocompatible mesh that releases a chemotherapy drug to a specific tumor, thus eliminating adverse side effects that can happen with systemic chemotherapy procedures.

Pulse oximeters’ inaccuracy highlights digital equity issues.

Senseonics has a longer runway in the CGM market. However, Dexcom has been busy building out its offerings until it wins approval for G7.

Quickly catch up on the latest medtech news from Medtronic, Abbott, Dexcom, and others.

Qiagen CEO shares story of one lab's undeterred commitment in Ukraine.

Paige now has CE-IVD and UKCA marks for a new AI medical device software designed to help pathologists detect if breast cancer has spread to lymph nodes.

The first results of a clinical trial show the safety and therapeutic potential of transient repeated blood-brain-barrier disruption in Alzheimer’s patients.

The Dexcom One will be available to diabetes patients in the UK in May. Here's what you should know about the new continuous glucose monitoring system.